<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://142-54-23-223.fusionmedialtd.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 17 Jul 2026 05:40:29 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://142-54-23-223.fusionmedialtd.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Mizuho Starts Edap TMS SA (FOCL) at Outperform</title>
   <link>http://www.streetinsider.com/New+Coverage/Mizuho+Starts+Edap+TMS+SA+%28FOCL%29+at+Outperform/26781317.html</link>
   <description>&lt;p&gt;Mizuho analyst Anthony Petrone initiates coverage on Edap TMS SA (NASDAQ: FOCL) with a Outperform rating and a price target of $15.00.&lt;/p&gt;&lt;p&gt;The analyst comments: “Our OP rating on FOCL shares is predicated on a combination of bullish findings from our July 2026 Urology survey (n=25) that points toward a High -Intensity Frequency Ultrasound (HIFU) inflection in prostate cancer along with what we see as a pair of free call options in Benign Prostatic Hyperplasia (BPH) and Endometriosis (EDM). High-level survey findings are: a) real-world outcomes for HIFU are superior to radical prostatectomy in terms of much lower severe adverse events</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/Mizuho+Starts+Edap+TMS+SA+%28FOCL%29+at+Outperform/26781317.html</guid>
   <pubDate>Fri, 17 Jul 2026 05:40:29 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	  </item>
  <item>
   <title>Mizuho Starts Edap TMS SA (FOCL) at Outperform</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Mizuho+Starts+Edap+TMS+SA+%28FOCL%29+at+Outperform/26781317.html</link>
   <description>&lt;p&gt;Mizuho analyst Anthony Petrone initiates coverage on Edap TMS SA (NASDAQ: FOCL) with a Outperform rating and a price target of $15.00.&lt;/p&gt;&lt;p&gt;The analyst comments: “Our OP rating on FOCL shares is predicated on a combination of bullish findings from our July 2026 Urology survey (n=25) that points toward a High -Intensity Frequency Ultrasound (HIFU) inflection in prostate cancer along with what we see as a pair of free call options in Benign Prostatic Hyperplasia (BPH) and Endometriosis (EDM). High-level survey findings are: a) real-world outcomes for HIFU are superior to radical prostatectomy in terms of much lower severe adverse events</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Mizuho+Starts+Edap+TMS+SA+%28FOCL%29+at+Outperform/26781317.html</guid>
   <pubDate>Fri, 17 Jul 2026 05:40:29 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	  </item>
  <item>
   <title>FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Announces+Successful+Launch+of+First+Commercial+Endometriosis+Focal+One%C2%AE+Program+in+Europe+with+Treatment+of+Initial+Patients/26709524.html</link>
   <description>&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients &lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  30, 2026  (GLOBE NEWSWIRE) --  FocalTherics™ (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced the launch of the first European commercial endometriosis Focal One® Program and treatment of initial patients at Toulouse University Hospital in Toulouse, France. The hospital launched their endometriosis Focal One program following the acquisition of the system with the intention of utilizing it for treating both deep infiltrating endometriosis and prostate cancer. This launch</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Announces+Successful+Launch+of+First+Commercial+Endometriosis+Focal+One%C2%AE+Program+in+Europe+with+Treatment+of+Initial+Patients/26709524.html</guid>
   <pubDate>Tue, 30 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	  </item>
  <item>
   <title>FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Announces+Successful+Launch+of+First+Commercial+Endometriosis+Focal+One%C2%AE+Program+in+Europe+with+Treatment+of+Initial+Patients/26709524.html</link>
   <description>&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients &lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  30, 2026  (GLOBE NEWSWIRE) --  FocalTherics™ (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced the launch of the first European commercial endometriosis Focal One® Program and treatment of initial patients at Toulouse University Hospital in Toulouse, France. The hospital launched their endometriosis Focal One program following the acquisition of the system with the intention of utilizing it for treating both deep infiltrating endometriosis and prostate cancer. This launch</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Announces+Successful+Launch+of+First+Commercial+Endometriosis+Focal+One%C2%AE+Program+in+Europe+with+Treatment+of+Initial+Patients/26709524.html</guid>
   <pubDate>Tue, 30 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	  </item>
  <item>
   <title>Form  8-K        EDAP TMS SA               For: Jun 26</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EDAP+TMS+SA+++++++++++++++For%3A+Jun+26/26698679.html</link>
   <description>si-local-file:///var/storage/secattach/20260626/26698679.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EDAP+TMS+SA+++++++++++++++For%3A+Jun+26/26698679.html</guid>
   <pubDate>Fri, 26 Jun 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	  </item>
  <item>
   <title>Form  8-K        EDAP TMS SA               For: Jun 26</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EDAP+TMS+SA+++++++++++++++For%3A+Jun+26/26698679.html</link>
   <description>si-local-file:///var/storage/secattach/20260626/26698679.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EDAP+TMS+SA+++++++++++++++For%3A+Jun+26/26698679.html</guid>
   <pubDate>Fri, 26 Jun 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	  </item>
  <item>
   <title>Form  8-K        EDAP TMS SA               For: Jun 26</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EDAP+TMS+SA+++++++++++++++For%3A+Jun+26/26698679.html</link>
   <description>si-local-file:///var/storage/secattach/20260626/26698679.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++EDAP+TMS+SA+++++++++++++++For%3A+Jun+26/26698679.html</guid>
   <pubDate>Fri, 26 Jun 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical </title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical+/26650422.html</link>
   <description>&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical+/26650422.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical </title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical+/26650422.html</link>
   <description>&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical+/26650422.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
 </channel>
</rss>
